GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » Effective Interest Rate on Debt %

Duopharma Biotech Bhd (XKLS:7148) Effective Interest Rate on Debt % : 4.91% (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Duopharma Biotech Bhd's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was RM25.0 Mil. Duopharma Biotech Bhd's average total debt for the quarter that ended in Mar. 2025 was RM508.4 Mil. Therefore, Duopharma Biotech Bhd's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 4.91%.


Duopharma Biotech Bhd Effective Interest Rate on Debt % Historical Data

The historical data trend for Duopharma Biotech Bhd's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd Effective Interest Rate on Debt % Chart

Duopharma Biotech Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 1.82 2.18 3.61 4.84

Duopharma Biotech Bhd Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.17 5.20 5.32 4.49 4.91

Competitive Comparison of Duopharma Biotech Bhd's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duopharma Biotech Bhd's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's Effective Interest Rate on Debt % falls into.


;
;

Duopharma Biotech Bhd Effective Interest Rate on Debt % Calculation

Duopharma Biotech Bhd's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -25.772/( (548.848+515.821)/ 2 )
=-1  *  -25.772/532.3345
=4.84 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=482.378 + 66.47
=548.848

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=467.278 + 48.543
=515.821

Duopharma Biotech Bhd's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -24.984/( (515.821+500.901)/ 2 )
=-1  *  -24.984/508.361
=4.91 %

where

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=467.278 + 48.543
=515.821

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=460.32 + 40.581
=500.901

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Duopharma Biotech Bhd  (XKLS:7148) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Duopharma Biotech Bhd Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.

Duopharma Biotech Bhd Headlines

No Headlines